LMO2 and gene therapy for severe combined immunodeficiency.

LMO2 and gene therapy for severe combined immunodeficiency.

Bibliographic Details
Main Authors:	Fischer, A, Abina, S, Thrasher, A, von Kalle, C, Cavazzana-Calvo, M
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
by: McCormack, M, et al.
Published: (2004)

Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice.
by: Tse, E, et al.
Published: (2004)

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
by: Hacein-Bey-Abina, S, et al.
Published: (2003)

Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency
by: Claudia A Montiel-Equihua, et al.
Published: (2009-12-01)

Immune Reconstitution After Gene Therapy Approaches in Patients With X-Linked Severe Combined Immunodeficiency Disease
by: Elena Blanco, et al.
Published: (2020-11-01)

Gene therapy for Whiskott–Aldrich syndrome: The latest news
by: Marina Cavazzana, et al.
Published: (2022-04-01)

Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency
by: Valentina Poletti, et al.
Published: (2018-06-01)

Gene therapy and genome editing for primary immunodeficiency diseases
by: Zhi-Yong Zhang, et al.
Published: (2020-03-01)

Research and Clinical Significance of the Differentially Expressed Genes TP63 and LMO4 in Human Immunodeficiency Virus-Related Penile Squamous Cell Carcinoma
by: Wenrui Xue PhD, et al.
Published: (2021-04-01)

A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma
by: Yifei Liu, et al.
Published: (2019-09-01)

Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
by: Utpal P Davé, et al.
Published: (2009-05-01)

Genetics of severe combined immunodeficiency
by: Rajni Kumrah, et al.
Published: (2020-03-01)

LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia
by: Ruggero, K, et al.
Published: (2016)

LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia
by: Ruggero, K, et al.
Published: (2016)

Expression of Lmo2 in Prostate Carcinoma and Adjacent Prostatic Parenchyma
by: Božo Krušlin, et al.
Published: (2018-01-01)

High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia
by: Lili Wu, et al.
Published: (2015-06-01)

The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish.
by: Patterson, L, et al.
Published: (2007)

Preclinical ex vivo IL2RG gene therapy using autologous hematopoietic stem cells as an effective and safe treatment for X-linked severe combined immunodeficiency disease
by: Mingfeng Hu, et al.
Published: (2025-05-01)

Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined Immunodeficiency
by: Samantha L. Ginn, et al.
Published: (2017-03-01)

An antibody inhibitor of the LMO2-protein complex blocks its normal and tumorigenic functions.
by: Nam, C, et al.
Published: (2008)

A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency
by: Chantal Lagresle-Peyrou, et al.
Published: (2020-01-01)

The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.
by: McCormack, M, et al.
Published: (2003)

Combating oncogene activation associated with retrovirus-mediated gene therapy of X-linked severe combined immunodeficiency
by: B.E. Strauss, et al.
Published: (2007-05-01)

The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal.
by: McCormack, M, et al.
Published: (2010)

Real-time definition of non-randomness in the distribution of genomic events.
by: Ulrich Abel, et al.
Published: (2007-01-01)

Regulation of LMO2 mRNA and protein expression in erythroid differentiation
by: Stephen J. Brandt, et al.
Published: (2009-04-01)

LMO2 at 25 years: a paradigm of chromosomal translocation proteins
by: Jennifer Chambers, et al.
Published: (2015-01-01)

Gene Therapy for Primary Immunodeficiency
by: Benjamin C. Houghton, et al.
Published: (2021-01-01)

Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of LMO1.
by: Jie Lu, et al.
Published: (2015-01-01)

Associations between LMO1 gene polymorphisms and central nervous system tumor susceptibility
by: Huiran Lin, et al.
Published: (2021-12-01)

Bacterial and Pneumocystis Infections in the Lungs of Gene-Knockout Rabbits with Severe Combined Immunodeficiency
by: Jun Song, et al.
Published: (2018-03-01)

Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector.
by: Satoshi Horino, et al.
Published: (2013-01-01)

The role of LMO2 in development and in T cell leukemia after chromosomal translocation or retroviral insertion.
by: Nam, C, et al.
Published: (2006)

Retrospective TREC testing of newborns with Severe Combined Immunodeficiency and other primary immunodeficiency diseases
by: O. Jilkina, et al.
Published: (2014-01-01)

The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice.
by: Yamada, Y, et al.
Published: (2000)

Economic Evaluation of Newborn Screening for Severe Combined Immunodeficiency
by: Sophy T. F. Shih, et al.
Published: (2022-07-01)

MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis
by: Nadia Felli, et al.
Published: (2009-04-01)

A dissected LMO2 functional analysis and clinical relevance in brain gliomas
by: Mei Yuan, et al.
Published: (2023-03-01)

LMO2 is essential to maintain the ability of progenitors to differentiate into T-cell lineage in mice
by: Ken-ichi Hirano, et al.
Published: (2021-08-01)

LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
by: Stephen Smith, et al.
Published: (2014-01-01)